Form 8-K - Current report:
SEC Accession No. 0001193125-24-282043
Filing Date
2024-12-19
Accepted
2024-12-19 16:30:52
Documents
13
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K d886973d8k.htm   iXBRL 8-K 29247
  Complete submission text file 0001193125-24-282043.txt   152672

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lfst-20241219.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lfst-20241219_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lfst-20241219_pre.xml EX-101.PRE 11260
15 EXTRACTED XBRL INSTANCE DOCUMENT d886973d8k_htm.xml XML 3648
Mailing Address 4800 N. SCOTTSDALE ROAD SUITE 2500 SCOTTSDALE AZ 85251
Business Address 4800 N. SCOTTSDALE ROAD SUITE 2500 SCOTTSDALE AZ 85251 602-767-2100
LifeStance Health Group, Inc. (Filer) CIK: 0001845257 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40478 | Film No.: 241563762
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)